Drug search by name

Niraparib Tosylate and MDS/AML

Result of checking the interaction of drug Niraparib Tosylate and disease MDS/AML for safety when used together.

Check result:

Niraparib Tosylate <> MDS/AML

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Myelodysplastic Syndrome/Acute Myeloid Leukemia (MDS/AML), including cases with fatal outcome, have been reported with the use of niraparib. It is recommended to use caution when using this agent in patients with MDS/AML, its use must be weighed against the risk. Discontinue the use of niraparib in patients who develop MDS/AML.

Niraparib Tosylate

Generic Name: niraparib

Brand Name: Zejula

Synonyms: Niraparib

What is Niraparib Tosylate?